OC90: A Potential Drug Target (G729330)

Target Name: OC90

NCBI ID: G729330

OC90

OC90: A Potential Drug Target

OC90 (Oc90) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidney. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. OC90 is unique due to its unique structure and its ability to interact with various signaling pathways.

The search for new drug targets is a critical aspect of modern medicine. Drug resistance is a major problem in the pharmaceutical industry, and researchers are always looking for new and innovative ways to treat diseases. OC90 is a protein that has been identified as a potential drug target, and its unique structure and interactions with various signaling pathways make it an attractive target for research.

Structure and Function

OC90 is a protein that is composed of 254 amino acid residues. It has a unique structure that is characterized by a long amino acid sequence that is involved in the formation of a unique dimeric complex. This dimeric complex is composed of two distinct subunits that are held together by a disulfide bond.

The first subunit of OC90 is a 144 amino acid long sequence that is involved in the formation of the dimeric complex. This sequence is responsible for the protein's unique structure and its ability to interact with various signaling pathways. The second subunit of OC90 is a 60 amino acid long sequence that is responsible for the protein's ability to interact with the cytoskeleton.

OC90's unique structure and its ability to interact with various signaling pathways make it an attractive target for research. One of the most significant signaling pathways that OC90 is involved in is the PI3K/Akt signaling pathway. This signaling pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

In addition to its involvement in the PI3K/Akt signaling pathway, OC90 is also involved in the regulation of other signaling pathways, including the TGF-β signaling pathway and the NF-kappa-B signaling pathway. These signaling pathways are involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

Drug Interaction with OC90

OC90 is a protein that is involved in multiple cellular processes, making it an attractive target for drug research. One of the most promising strategies for drug research with OC90 is the use of small molecules to inhibit its activity. This can be done by binding to specific residues on the protein and preventing it from interacting with other signaling pathways.

There is a growing interest in the use of small molecules as drug targets because they are non-toxic and have a low potential for adverse effects. In addition, small molecules can be easily synthesized and tested for effectiveness. This is an attractive advantage for drug research with OC90 because it allows for the rapid and efficient identification of potential drug targets.

Conclusion

OC90 is a unique protein that is involved in multiple cellular processes. Its unique structure and its ability to interact with various signaling pathways make it an attractive target for drug research. The use of small molecules as drug targets is an attractive strategy for the identification of new and innovative treatments for various diseases. Further research is needed to fully understand the unique properties of OC90 and its potential as a drug target.

Protein Name: Otoconin 90

Functions: Major protein of the otoconia, a calcium carbonate structure in the saccule and utricle of the ear. Together with OTOL1, acts as a scaffold for otoconia biomineralization: sequesters calcium and forms interconnecting fibrils between otoconia that are incorporated into the calcium crystal structure. Together with OTOL1, modulates calcite crystal morphology and growth kinetics. It is unlikely that this protein has phospholipase A2 activity

The "OC90 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OC90 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets